Evidence map›Paper›PMID 41601621›Full record

ArticleFrontiers in immunology2025

Identification and validation of

Ting-Juan Zhang, Ran Chang, Fei Xie, Zi-Jun Xu, Ming-Qiang Chu, Xiao-Chi Wu, Jun Qian, Jing-Dong Zhou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ting-Juan Zhang *Department of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, China.
Ran Chang *Department of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, China.
Fei Xie *Department of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, China.
Zi-Jun XuDepartment of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, China.
Ming-Qiang ChuDepartment of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, China.
Xiao-Chi WuDepartment of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, China.
Jun QianDepartment of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, China.
Jing-Dong ZhouDepartment of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Aberrant expression of Homeobox ( Methods: We first systematically analyzed the association of Results: Hypomethylation of Conclusions:

Indexed as

Biomarkers, TumorDNA MethylationEpigenesis, GeneticHomeodomain ProteinsLeukemia, Myeloid, AcuteDNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3AFemaleGene Expression Regulation, LeukemicHumansMicroRNAsMiddle AgedMutationNucleophosminPrognosisBiomarkers, TumorDNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3AHomeodomain ProteinsHoxB3 protein, humanMicroRNAsNPM1 protein, humanNucleophosminAMLHOXBHoxB3hypomethylationprognosisregulation

Identifiers

PMID41601621
PMCPMC12832762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.